How TB and COVID-19 compare: an opportunity to integrate both control programmes.

Echeverría, G; Espinoza, W; de Waard, J H

Echeverría, G; Espinoza, W; de Waard, J H.

Echeverría G; Instituto de Investigación en Zoonosis, Universidad Central del Ecuador, Quito.
Espinoza W; Área de Tuberculosis, Laboratorio Clínico del Hospital, Hospital de Especialidades Eugenio Espejo, Quito.
de Waard JH; One Health Research Group, Universidad de Las Américas, Facultad de Ciencias de la Salud, Quito, Ecuador <email></email>, Email: jacobusdeward@gmail.com.

Int J Tuberc Lung Dis ; 24(9): 971-974, 2020 09 01.

Article in English | MEDLINE | ID: covidwho-1024774

Subject(s)

Betacoronavirus; Communicable Disease Control/organization & administration; Coronavirus Infections/epidemiology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; Pneumonia, Viral/prevention & control; Tuberculosis/epidemiology; Tuberculosis/prevention & control; COVID-19; Coronavirus Infections/diagnosis; Humans; Pneumonia, Viral/diagnosis; SARS-CoV-2; Tuberculosis/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Tuberculosis / Communicable Disease Control / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Int J Tuberc Lung Dis Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google